Unraveling the mechanism of platelet aggregation suppression by monoterpenoids
LE Nikitina, RS Pavelyev, IR Gilfanov, SV Kiselev… - Bioengineering, 2022 - mdpi.com
Platelet aggregation causes various diseases and therefore challenges the development of
novel antiaggregatory drugs. In this study, we report the possible mechanism of platelet …
novel antiaggregatory drugs. In this study, we report the possible mechanism of platelet …
[Retracted] Identification of Sports Athletes' High‐Strength Sports Injuries Based on NMR
W Zhou, H Chu - Scanning, 2022 - Wiley Online Library
In order to study the high‐strength sports injury in sports, this paper proposes a method
based on NMR to identify the high‐strength sports injury of sports athletes. This method …
based on NMR to identify the high‐strength sports injury of sports athletes. This method …
[HTML][HTML] (Gd3+) Complexation with oligopeptide (SFVG) and amyloid peptide (Aβ13–23) in aqueous solution by NMR spectroscopy
AS Tarasov, IZ Rakhmatullin, DS Blokhin… - Results in …, 2023 - Elsevier
Gadolinium (III) ion, which belongs to the subgroup of transition metal ions, has practical
importance for magnetic resonance imaging (MRI) with contrast. The accumulation of …
importance for magnetic resonance imaging (MRI) with contrast. The accumulation of …
[PDF][PDF] Unraveling the Mechanism of Platelet Aggregation Suppression by Monoterpenoids
KV Vasilevich, OO Vyacheslavovna, PR Sergeevich… - dspace.kpfu.ru
Platelet aggregation causes various diseases and therefore challenges the development of
novel antiaggregatory drugs. In this study, we report the possible mechanism of platelet …
novel antiaggregatory drugs. In this study, we report the possible mechanism of platelet …
[PDF][PDF] Investigation of Lovastatine with transition metal by NMR
TR Islamov, OV Aganova, AR Julmetov, VV Klochkov - kpfu.ru
One of the current tasks is to find ways to modernize existing drugs in order to reduce their
toxicity by adding metals to their structure. The choice of ligand for the synthesis of the metal …
toxicity by adding metals to their structure. The choice of ligand for the synthesis of the metal …
[PDF][PDF] Investigation of Lovastatine with transition metal by NMR
KV Vasilevich, JA Rafailevich, IT Rafisovich… - dspace.kpfu.ru
One of the current tasks is to find ways to modernize existing drugs in order to reduce their
toxicity by adding metals to their structure. The choice of ligand for the synthesis of the metal …
toxicity by adding metals to their structure. The choice of ligand for the synthesis of the metal …